Skip to main content
. 2022 May 5;23(9):5152. doi: 10.3390/ijms23095152
EC50 effective concentration of oxidizers or fullerenols which inhibited bioluminescence intensity by 50%
F fullerenol
FMN flavinmononucleotide
Gd@Fln Gd@C82Oy(OH)x, where x + y = 40–42
I bioluminescence intensity
IR infrared
MRI magnetic resonance imaging
NADH nicotinamide adenine dinucleotide, disodium salt, reduced
Ox model oxidizer
ROS reactive oxygen species
T bioluminescence induction period
XPS X-ray photoelectron spectroscopy